RLAY - Relay Therapeutics, Inc.

QQQ $ 455.25 $ 5.77 (1.29 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 6.05 (1.12 %)

TLT $ 99.96 $ 0.43 (0.43 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 9.51

Open

$ 7.13

Bid

$ 9.50 x 100

Ask

$ 9.53 x 400

Day's Range

$ 7.05 - $ 10.70

52 Week Range

$ 5.70 - $ 12.14

Volume

19,068,541

Average Volume

Market Cap

1.27B

Beta (5Y Monthly)

$ 1.90

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	02-22-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	02-23-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-24-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-13-2021	03-31-2021	10-Q
15	03-25-2021	12-31-2020	10-K
16	11-12-2020	09-30-2020	10-Q
17	08-27-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

dow-jumps-over-1-following-last-weeks-selloff-investor-sentiment-improves-but-fear--greed-index-remains-in-fear-zone

Dow Jumps Over 1% Following Last Week's Se...
09/10/2024 06:12:41

Relay Therapeutics Commences Public Offeri...
09/09/2024 20:35:16

Relay Therapeutics also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%)...

Crude Oil Gains Over 1%; Relay Therapeutic...
09/09/2024 18:16:34

nasdaq-surges-over-1-us-wholesale-inventories-rise-02-in-july

Nasdaq Surges Over 1%; US Wholesale Invent...
09/09/2024 16:04:18

relay-therapeutics-advances-towards-pivotal-trial-as-it-shares-encouraging-breast-cancer-data-in-heavily-pretreated-patients

Relay Therapeutics Advances Towards Pivota...
09/09/2024 15:30:00

Monday, Relay Therapeutics Inc. (NASDAQ:RLAY) shared interim data for RLY-2608 from ReDiscover study, an ongoing first-in-human...

terns-pharmaceuticals-boeing-tesla-and-other-big-stocks-moving-higher-on-monday

Terns Pharmaceuticals, Boeing, Tesla And O...
09/09/2024 14:13:07

US Stocks Higher; Dow Surges Over 200 Points
09/09/2024 13:54:24

Relay Therapeutics Reports Interim Data fo...
09/09/2024 10:56:53

Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by ...

JP Morgan Maintains Overweight on Relay Th...
08/07/2024 18:18:47

JP Morgan analyst Eric Joseph maintains Relay Therapeutics (NASDAQ:RLAY) with a Overweight and lowers the price target from ...

Expert Ratings For Relay Therapeutics
08/07/2024 18:00:35

Oppenheimer Maintains Outperform on Relay ...
08/07/2024 11:52:53

Oppenheimer analyst Matthew Biegler maintains Relay Therapeutics (NASDAQ:RLAY) with a Outperform and lowers the price target...

Relay Therapeutics Q2 2024 GAAP EPS $(0.69...
08/06/2024 20:56:14

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(...

Barclays Maintains Overweight on Relay The...
07/26/2024 11:35:44

Barclays analyst Peter Lawson maintains Relay Therapeutics (NASDAQ:RLAY) with a Overweight and lowers the price target from ...

JMP Securities Maintains Market Outperform...
07/18/2024 11:27:08

JMP Securities analyst Silvan Tuerkcan maintains Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and lowers the pr...

Expert Ratings For Relay Therapeutics
07/17/2024 12:01:40

HC Wainwright & Co. Maintains Buy on Relay...
07/17/2024 10:22:28

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price targ...

Relay Therapeutics Receives Notice Of Term...
07/16/2024 20:19:31

Effective In 180 Days; Agreement Involved Development Of Migoprotafib (GDC-1971); No Further Payments Or Obligations After Term...

Expert Ratings For Relay Therapeutics
06/07/2024 12:00:41

HC Wainwright & Co. Reiterates Buy on Rela...
06/07/2024 10:57:53

HC Wainwright & Co. analyst Robert Burns reiterates Relay Therapeutics (NASDAQ:RLAY) with a Buy and maintains $20 price ...

Relay Therapeutics Cash Guidance Remains U...
06/06/2024 12:23:45

The new programs announced today do not change cash guidance, which is expected to fund operations into the second half of 2026.